IQVIA Holdings Inc. (IQV) has reported strong Q4 2024 Earnings with a 41% rise in free cash flow. This is alongside a substantial R&D backlog of $31.1B promising future growth. Various investment firms including Graphene Investments SAS, Bleakley Financial Group LLC, DAVENPORT & Co LLC ,and Generate Investment Management Ltd has increased their position in the company's stock. However, some entities such as abrdn plc, Calamos Advisors LLC, Mirae Asset Global Investments Co. Ltd and Swedbank AB have reduced their IQVIA shares. Several investment firms are still bullish about IQVIA, with a “Buy” rating maintained despite adjusting the price target. NVIDIA and IQVIA have announced a collaboration aiming to drive healthcare advancements using AI. However, UBS Group's pessimistic forecast, a lag in shareholder's YoY returns, and reduced near-term outlook for its R&D Solutions segment brought some concerns.
Iqvia Holdings IQV News Analytics from Fri, 13 Sep 2024 07:00:00 GMT to Sat, 08 Feb 2025 21:55:11 GMT -
Rating 6
- Innovation 3
- Information 8
- Rumor -4
